Global Sexually Transmitted Diseases Diagnostics Market Size To Grow USD 7.6 Billion by 2032 | CAGR of 8%

Category: Healthcare

RELEASE DATE May 2023
REPORT ID SI1953

Global Sexually Transmitted Diseases Diagnostics Market worth $7.6 billion by 2032

According to a research report published by Spherical Insights & Consulting, the Global Sexually Transmitted Diseases Diagnostics Market Size to grow from USD 3.9 billion in 2021 to USD 7.6 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 8% during the forecast period.

 

Sexually Transmitted Diseases Diagnostics Market

Get more details on this report -

Request Free Sample PDF

Browse key industry insights spread across 210 pages with 132 market data tables and figures & charts from the report onGlobal Sexually Transmitted Diseases Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Types (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing), By Location Of Testing (Laboratory Testing, Point of Care Testing), By Testing Devices (Laboratory Devices, Point of Care Devices), by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2032" Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/sexually-transmitted-diseases-diagnostics-market

 

STD stands for sexually transmitted diseases, also known as venereal diseases (VDs), which are frequently spread through sexual activity, blood transfusions, breastfeeding, and use of contaminated needles for drug usage. These conditions don't show any symptoms and are only identified by numerous tests, including blood, urine, and fluid samples. STDs caused by bacteria can be treated with antibiotics and antiviral drugs. Some of the instruments used to diagnose the disorder include absorbance microplate readers, flow cytometers, scattering machines, and immunochromatographic assays.

 

COVID 19 Impact

On a global scale, the COVID 19 pandemic is expected to have a substantial influence on the market for diagnosing sexually transmitted illnesses. According to the Quest Diagnostics 2020 Health Trends, COVID 19 instances have significantly increased while screening rates for diseases like chlamydia and gonorrhoea declined throughout the pandemic. In fact, the researchers discovered that during the early stages of the pandemic, screening and testing for sexually transmitted illnesses decreased by 63% for males and 59% for women.

 

As individuals become more aware of STD disorders and infection, there will be an increase in the demand for sexually transmitted disease diagnostics, which will increase the market share for these diagnostics throughout the forecast period. The growing number of patient examinations, government programmes and campaigns, as well as rising public knowledge of the infection and other factors, are what primarily drive the market share for diagnostics for sexually transmitted diseases. Due to improvements in the technologies used for sexually transmitted diseases diagnoses, the market share for these services has significantly increased over the past several years. In addition to this, a number of other factors, such as growing public awareness and patient education, are fueling the market's expansion. Additionally, the market is expected to be driven by the demand for diagnostics for sexually transmitted diseases due to an increase in STD incidence, government initiatives, and patient awareness raised by educational activities. Due to the growing availability of technologically advanced diagnostics equipment that provide more accurate test results, it is projected that the market for diagnosing sexually transmitted diseases would grow at a significant rate.

 

Type Insights

Chlamydia Testing segment is dominating the market over the forecast period

On the basis of type, the global sexually transmitted diseases diagnostics market is segmented into Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Chancroid Testing. Among these, Chlamydia Testing segment is dominating the market with the largest market share over the forecast period. The segment is expected to rise as more people contract illnesses such trichomonas vaginitis and vaginitis, as well as syphilis, chlamydia, herpes simplex virus, gonorrhoea, human papillomavirus, chancroid, and immunodeficiency virus.

 

Location of Testing Insights

Laboratory testing segment holds the largest market share over the forecast period

Based on location of testing, the global sexually transmitted diseases diagnostics market is laboratory testing and point of care testing. Among these, laboratory testing is dominating the market with the largest market share over the forecast period. Although more precise methods are used in both public health labs and private or commercial labs, laboratory testing is a difficult process. Even though point-of-care testing uses testing kits, which are quicker, the results might not be reliable.

 

Testing Devices Insights

Laboratory devices segment to dominate the market over the forecast period

On the basis of testing devices, the globally sexually transmitted diseases diagnostics market is segmented into laboratory devices and point of care devices. The laboratory equipment includes heat cyclers and lateral flow readers. flow cytometers, absorbance microplate readers, differential light scattering equipment, and PCR. On the other hand, due to the rising number of product launches, the point of care testing devices sector is predicted to experience the quickest market growth throughout the projection period.

 

Regional Insights

North America is dominating the market with the largest market share over the forecast period

 

Sexually Transmitted Diseases Diagnostics Market

Get more details on this report -

Request Free Sample PDF

North America is dominating the market with the largest market share over the forecast period. The acceptance of technologically advanced products is rising, which is a sign of industry development. Additionally, during the course of the projected period, the advent of fresh POC testing ideas, the availability of trustworthy STD testing services from public health laboratories, and insurance coverage will all contribute to market growth. Due to the availability of public healthcare insurance programmes that promote healthcare knowledge among the populace, North America currently has a stranglehold on the global market for diagnosing sexually transmitted diseases. The FDA-approved availability of sophisticated STD diagnostic technologies is another factor that supports the market's growth.

 

On the other hand, over the anticipated period, Asia Pacific would have the fastest market expansion. The economic prosperity of these regions, which encourages the development of STD diagnostics, is one of the driving factors. Another is the rising rates of sexually transmitted illnesses in the underdeveloped countries of Asia and the Pacific.

 

Major vendors in the Global Sexually Transmitted Diseases Diagnostics Market include Abbott, aposcience, BD, Biocartis, bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid, Danaher, DiaSorin, GenMark Diagnostics, Inc., Hologic Inc., OraSure Technologies, Inc., Qualigen Inc, Quidel Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, MedMira Inc.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global Sexually Transmitted Diseases Diagnostics Market based on the below-mentioned segments:

 

Sexually Transmitted Diseases Diagnostics Market, Type Analysis

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing

Sexually Transmitted Diseases Diagnostics Market, Location of Testing Analysis

  • Laboratory Testing
  • Point of Care Testing

Sexually Transmitted Diseases Diagnostics Market, Testing Devices Analysis

  • Laboratory Devices
  • Point of Care Devices

 

Sexually Transmitted Diseases Diagnostics Market, Regional Analysis

·       North America

o   US

o   Canada

o   Mexico

·          Europe

o   Germany

o   Uk

o   France

o   Italy

o   Spain

o   Russia

o   Rest of Europe

·          Asia Pacific

o   China

o   Japan

o   India

o   South Korea

o   Australia

o   Rest of Asia Pacific

·          South America

o   Brazil

o   Argentina

o   Rest of South America

·          Middle East & Africa

o   UAE

o   Saudi Arabia

o   Qatar

o   South Africa

o   Rest of Middle East & Africa

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies